Recruiting Spinal Muscular Atrophy Studies in Indianapolis
About Spinal Muscular Atrophy Clinical Trials in Indianapolis
Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes loss of motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant death. Revolutionary gene therapies and SMN-enhancing drugs have transformed treatment.
There are currently 12 spinal muscular atrophy clinical trials recruiting participants in Indianapolis, IN. These studies are seeking a combined 4,414 participants. Research is being sponsored by Indiana University, AbbVie, Greg Durm, MD and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Spinal Muscular Atrophy Clinical Trials in Indianapolis — FAQ
Are there spinal muscular atrophy clinical trials in Indianapolis?
Yes, there are 12 spinal muscular atrophy clinical trials currently recruiting in Indianapolis, IN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Indianapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.
Are clinical trials in Indianapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.
What spinal muscular atrophy treatments are being tested?
The 12 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for spinal muscular atrophy.
Data updated July 13, 2026 from ClinicalTrials.gov